|
|
.
See Category: Diseases of the eye and adnexa
ICD-10 (CM) Code and Descriptor
|
H46.9 |
Unspecified optic neuritis
|
H469 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 37.24%
|
23.43%
|
13.30%
|
8.66%
|
4.63%
|
3.23%
|
2.27%
|
1.75%
|
1.54%
|
0.79%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for H46.9*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
1,606
|
1,611
|
|
92083
|
EXTENDED VISUAL FIELD XM |
884
|
884
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
816
|
819
|
|
92133
|
CPTRZD OPH DX IMG PST SGM ON |
686
|
686
|
|
70543
|
MRI ORBT/FAC/NCK W/O &W/DYE |
465
|
465
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
442
|
442
|
|
86140
|
C-REACTIVE PROTEIN |
395
|
395
|
|
70553
|
MRI BRAIN STEM W/O & W/DYE |
395
|
396
|
|
85652
|
RBC SED RATE AUTOMATED |
372
|
372
|
|
96365
|
THER/PROPH/DIAG IV INF INIT |
340
|
340
|
|
J2930
|
METHYLPREDNISOLONE INJECTION |
321
|
2,085
|
|
86255
|
FLUORESCENT ANTIBODY SCREEN |
309
|
553
|
|
80053
|
COMPREHEN METABOLIC PANEL |
252
|
252
|
|
G1004
|
CDSM NDSC |
218
|
270
|
|
82607
|
VITAMIN B-12 |
212
|
212
|
|
82164
|
ANGIOTENSIN I ENZYME TEST |
207
|
207
|
|
86780
|
TREPONEMA PALLIDUM |
203
|
209
|
|
92014
|
COMPRE OPH EXAM EST PT 1/> |
200
|
200
|
|
82565
|
ASSAY OF CREATININE |
188
|
188
|
|
A9585
|
GADOBUTROL INJECTION |
176
|
13,619
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
H46.9 related to the following DRG Codes:
123
|
